SIT INVESTMENT ASSOCIATES INC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 1 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2023$03,9130.0%0.00%
Q2 2023$03,9130.0%0.00%
Q1 2023$03,9130.0%0.00%
Q4 2022$03,9130.0%0.00%
Q3 2022$03,9130.0%0.00%
Q2 2022$03,9130.0%0.00%
Q1 2022$03,9130.0%0.00%
Q4 2021$03,9130.0%0.00%
Q2 2021$03,9130.0%0.00%
Q1 2021$03,9130.0%0.00%
Q4 2020$03,9130.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2021
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$22,387,0006.39%
First Washington CORP 185,250$893,0000.53%
PURA VIDA INVESTMENTS, LLC 80,500$388,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,382,0000.06%
EMERALD ADVISERS, LLC 163,540$788,0000.04%
Catalyst Capital Advisors LLC 70,000$337,0000.04%
Burt Wealth Advisors 2,625$13,0000.01%
Spark Investment Management LLC 15,500$74,0000.01%
MYCIO WEALTH PARTNERS, LLC 12,000$58,0000.01%
Nicholas Investment Partners, LP 19,188$92,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders